#bcsm

Dr Viansone on Balancing ADCs and Low-Toxicity Chemotherapy in HER2+ Breast Cancer | OncLive (onclive.com)

WATCH: Alessandro A. Viansone, MD, discusses balancing ADCs such as T-DXd against low-toxicity chemotherapy in HER2-positive breast cancer therapy de-escalation. @gustaveroussy.fr #bcsm #oncology www.onclive.com/view/dr-vian...

WATCH: Ajaz M. Khan, MD, MBA, CPE, spotlights the lidERA trial in breast cancer. @cityofhope.bsky.social #bcsm #oncology See our coverage of the data for more insights! www.onclive.com/view/giredes...

WATCH: Alessandro A. Viansone, MD, highlights potential future updates to the HER2-positive breast cancer treatment paradigm. @gustaveroussy.fr #bcsm #oncology Watch more insights from Dr Viansone on our site: www.onclive.com/view/dr-vian...